| Product Code: ETC7383486 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of viral vectors and vaccines to Grenada in 2024 show a diversification of sources, with top exporting countries being Barbados, India, Panama, South Korea, and Belgium. The market concentration, as measured by the HHI, has shifted from high to moderate in 2024, indicating a more balanced distribution of imports. The impressive compound annual growth rate (CAGR) of 24.01% from 2020 to 2024 highlights the increasing demand for these products in Grenada. Furthermore, the substantial growth rate of 67.54% from 2023 to 2024 suggests a rapid expansion of the market for viral vectors and vaccines in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Viral Vector and Vaccine Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Viral Vector and Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Viral Vector and Vaccine Market - Industry Life Cycle |
3.4 Grenada Viral Vector and Vaccine Market - Porter's Five Forces |
3.5 Grenada Viral Vector and Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Viral Vector and Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Grenada Viral Vector and Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Grenada |
4.2.2 Growing government initiatives to promote vaccination programs |
4.2.3 Advancements in viral vector and vaccine technology |
4.2.4 Rising awareness about the importance of immunization |
4.2.5 Collaborations between research institutions and pharmaceutical companies |
4.3 Market Restraints |
4.3.1 High cost of viral vector and vaccine development |
4.3.2 Stringent regulatory requirements for approval |
4.3.3 Limited access to healthcare facilities in remote areas of Grenada |
4.3.4 Concerns about vaccine safety and side effects |
4.3.5 Competition from traditional pharmaceutical products |
5 Grenada Viral Vector and Vaccine Market Trends |
6 Grenada Viral Vector and Vaccine Market, By Types |
6.1 Grenada Viral Vector and Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Viral Vector and Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Grenada Viral Vector and Vaccine Market Revenues & Volume, By Adenovirus, 2021- 2031F |
6.1.4 Grenada Viral Vector and Vaccine Market Revenues & Volume, By Fowlpox Virus, 2021- 2031F |
6.1.5 Grenada Viral Vector and Vaccine Market Revenues & Volume, By Attenuated Yellow Fever, 2021- 2031F |
6.1.6 Grenada Viral Vector and Vaccine Market Revenues & Volume, By Vaccinia Virus Vectors, 2021- 2031F |
6.2 Grenada Viral Vector and Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Grenada Viral Vector and Vaccine Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.2.3 Grenada Viral Vector and Vaccine Market Revenues & Volume, By Biopharmaceutical Companies, 2021- 2031F |
6.2.4 Grenada Viral Vector and Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Viral Vector and Vaccine Market Import-Export Trade Statistics |
7.1 Grenada Viral Vector and Vaccine Market Export to Major Countries |
7.2 Grenada Viral Vector and Vaccine Market Imports from Major Countries |
8 Grenada Viral Vector and Vaccine Market Key Performance Indicators |
8.1 Vaccine coverage rate in Grenada |
8.2 Number of clinical trials for viral vector and vaccine candidates in Grenada |
8.3 Funding allocated to viral vector and vaccine research and development in Grenada |
8.4 Rate of vaccine hesitancy among the population |
8.5 Number of partnerships between local and international organizations for vaccine development in Grenada |
9 Grenada Viral Vector and Vaccine Market - Opportunity Assessment |
9.1 Grenada Viral Vector and Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Viral Vector and Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Grenada Viral Vector and Vaccine Market - Competitive Landscape |
10.1 Grenada Viral Vector and Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Grenada Viral Vector and Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here